Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
ARYx Therapeutics Inc (ARYX)
OTHER OTC:ARYX
ARYx Therapeutics (ARYX) Stock Price & Analysis
4 Followers
ARYX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.01 - $0.01
Previous Close$0.01
Volume2.00K
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$14.56M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)N/A
Beta413.51
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.00%
Mutual Funds
1.55% Other Institutional Investors
98.45% Public Companies and
Individual Investors
ARYX FAQ
What was ARYx Therapeutics Inc’s price range in the past 12 months?
ARYx Therapeutics Inc lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is ARYx Therapeutics Inc’s market cap?
Currently, no data Available
When is ARYx Therapeutics Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ARYx Therapeutics Inc’s earnings last quarter?
Currently, no data Available
Is ARYx Therapeutics Inc overvalued?
According to Wall Street analysts ARYx Therapeutics Inc’s price is currently Overvalued.
Does ARYx Therapeutics Inc pay dividends?
ARYx Therapeutics Inc does not currently pay dividends.
What is ARYx Therapeutics Inc’s EPS estimate?
ARYx Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ARYx Therapeutics Inc have?
ARYx Therapeutics Inc has 33,462,000 shares outstanding.
What happened to ARYx Therapeutics Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ARYx Therapeutics Inc?
Currently, no hedge funds are holding shares in ARYX
---
Company Description
ARYx Therapeutics Inc
ARYx Therapeutics, Inc. discovers and develops drugs for large, chronic disease markets. Its products include Naronapride, a proprietary serotonin type 4 (5HT4) for the treatment of multiple gastrointestinal disorders; Budiodarone is a proprietary compound in Phase 2 development for the treatment of atrial fibrillation; Tecarfarin, a novel compound for oral anti-coagulation therapy; and ATI-9242, a typical antipsychotic for the treatment of schizophrenia and other psychiatric disorders. The company was founded on February 28, 1997 by Peter G. Milner and Pascal Druzgala and is headquartered in Fremont, CA.
---
Technical Analysis
---